United European Gastroenterology Journal

Papers
(The median citation count of United European Gastroenterology Journal is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-02-01 to 2025-02-01.)
ArticleCitations
Portal hypertension and hepatocellular carcinoma: Navigating uncharted waters131
Does pan‐enteric capsule endoscopy obviate magnetic resonance entero‐colonography in suspected Crohn's disease?88
Systemic therapies in hepatocellular carcinoma: A revolution?84
Recent developments in the management of ascites in cirrhosis82
Divergent trends of hospitalizations for upper and lower gastrointestinal bleeding based on population prescriptions of aspirin, proton pump inhibitors and Helicobacter pylori eradication thera76
Rare Case of Mantle Cell Lymphoma With Multiple Rectal Lesions75
Transplanting severely obese cirrhotic patients: Heavy clouds still on the horizon71
Milan ultrasound criteria are accurate in assessing disease activity in ulcerative colitis: external validation70
European guidelines on microscopic colitis: United European Gastroenterology and European Microscopic Colitis Group statements and recommendations64
Liver and spleen volumes are associated with prognosis of compensated and decompensated cirrhosis and parallel its natural history51
Analysis of tofacitinib safety in ulcerative colitis from the completed global clinical developmental program up to 9.2 years of drug exposure50
Temporal progression of pancreatic cancer computed tomography findings until diagnosis: A large‐scale multicenter study47
Role of compliance in Helicobacter pylori eradication treatment: Results of the European Registry on H. pylori management47
Analysis of the burden and economic impact of digestive diseases and investigation of research gaps and priorities in the field of digestive health in the European Region—White Book 2: Executive summa46
Medical guidelines must not be influenced by commercial interests46
Stunned by a stone—A curious case of belly trouble44
Issue Information42
39
Stools' donor recruitment, a challenge in pandemic times39
Gastrointestinal Guidelines app: Streamlining guideline awareness and adherence in gastroenterology34
Comparison of two strategies for the management of postoperative recurrence in Crohn’s disease patients with one clinical risk factor: A multicentre IG‐IBD study32
Colectomy in patients with ulcerative colitis is not associated to future diagnosis of primary sclerosing cholangitis32
 31
Genital warts and inflammatory bowel diseases: Danish real‐world evidence to assess patient‐relevant outcomes31
Real‐world use of endoscopic and histological indices in ulcerative colitis: Results of a global survey29
Young GI angle: European Specialty Examination in Gastroenterology and Hepatology exam: Tips and tricks28
The diagnostic yield of colonoscopic surveillance following resection of early age onset colorectal cancer27
Between progress and changing times: The journey of UEG Education Committee's chair26
Issue Information26
26
Issue Information25
The unmet need of personalized HCC screening—Lessons learned from the Swedish nationwide registries25
Early remodeling of the colonic mucosa after allogeneic hematopoietic stem cells transplantation: An open‐label controlled pilot study on 19 patients25
A stalk with no polyp—A muco‐submucosal elongated polyp in the duodenum24
Effectiveness of screening endoscopy for esophageal squamous cell carcinoma in Japanese males23
Issue Information23
23
22
UEGWeek: The modern School of Athens22
Malignancy rates in Crohn's disease patients with perianal fistula: A German retrospective cohort study21
Exploring the links between types 2 diabetes and liver‐related complications: A comprehensive review21
Letter of Thanks for UEG Week 2022 Reviewers21
Young GI angle: Living through a crisis: How to manage downturns in your career21
Lymphovascular invasion quantification could improve risk prediction of lymph node metastases in patients with submucosal (T1b) esophageal adenocarcinoma21
UEG's prospects for the future20
Endoscopy and histology in inflammatory bowel diseases patients: Complementary or alternatives?20
Self‐reported treatment effectiveness for Crohn's disease using a novel crowdsourcing web‐based platform20
Risk factors associated with liver‐related complications in diabetes: There may be more than meets the eye19
The role of an integrated referral program for patients with liver disease: A network between hub and spoke centers19
An intraprocedural bowel cleansing system for difficult‐to‐prepare patients—A multicenter prospective feasibility study18
Coexistent faecal incontinence and constipation: Common but frequently overlooked18
18
Reducing bureaucracy in clinical trials18
Health aspects of faecal incontinence are complex and multi‐layered18
Corrigendum18
Recurrent symptoms after achalasia treatment: The value of impedance analysis17
17
Monomorphic epitheliotropic T‐cell lymphoma of the small intestine17
Seeing the whole picture: Inflammatory bowel disease complications and extraintestinal manifestations on cross‐sectional imaging16
Capability of processed EEG parameters to monitor conscious sedation in endoscopy is similar to general anaesthesia16
16
Eosinophilic oesophagitis in Denmark: Population‐based incidence and prevalence in a nationwide study from 2008 to 201816
“Car body appearance and engine”: The morphology‐function correlation in chronic pancreatitis16
Association between pancreatic adenocarcinoma risk and concentration of organochlorine pesticides in adipose tissue and urine: A targeted‐screening analysis case‐control study (PESTIPAC)16
Reporting of endoscopy and histology of ulcerative colitis in routine clinical practice: How far we are!16
Close follow‐up is associated with fewer stricture formation and results in earlier detection of histological relapse in the long‐term management of eosinophilic esophagitis16
Table of Contents15
15
High vaccination coverage and infection rate result in a robust SARS‐CoV‐2‐specific immunity in the majority of liver cirrhosis and transplant patients: A single‐center cross‐sectional study15
Predicting de‐novo portal vein thrombosis after HCV eradication: A long‐term competing risk analysis in the ongoing PITER cohort15
SARS‐Cov‐2 vaccination is safe in autoimmune pancreatitis patients15
Faecal volatile organic compounds differ according to inflammatory bowel disease sub‐type, severity, and response to treatment in paediatric patients15
Symptomatic gallstone disease: Recurrence patterns and risk factors for relapse after first admission, the RELAPSTONE study15
Cold versus hot polypectomy/endoscopic mucosal resection–A review of current evidence14
Solitary pedunculated cap polyp in a patient with ulcerative colitis14
Issue Information14
Colocolonic intussusception as initial manifestation of polyposis coli associated colon cancer14
Fecal occult blood and calprotectin testing to prioritize primary care patients for colonoscopy referral: The advantage study14
Safety of tofacitinib in IBD: A tricky puzzle14
No evidence of association between inherited thrombophilia and increased risk of liver fibrosis14
The risk of hepatocellular carcinoma in cirrhosis differs by etiology, age and sex: A Swedish nationwide population‐based cohort study13
European Registry on Helicobacter pylori management: Single‐capsule bismuth quadruple therapy is effective in real‐world clinical practice13
Mucosal Healing in Inflammatory Bowel Diseases: Still too Many Irons on the Fire13
The incidence and outcome of postoperative hepatic encephalopathy in patients with cirrhosis13
Understanding progression of strictures in ileal Crohn's disease—The importance of setting methodological standards13
Therapeutic management of metabolic dysfunction associated steatotic liver disease13
Nodular Regenerative Hyperplasia: Report of 82 Patients and Systematic Review of Literature13
Artificial intelligence: The researcher's assistant or sheep in wolf's clothing?13
High prevalence of extended‐spectrum beta‐lactamase organisms and the COVID‐19 pandemic impact on donor recruitment for fecal microbiota transplantation in Hong Kong13
Opioid analgesia and severity of acute pancreatitis: An international multicentre cohort study on pain management in acute pancreatitis13
Selection of individuals who may benefit from pancreatic cancer surveillance13
Tonsillar Crohn's Disease13
Hepatitis D virus (HDV) prevalence in Austria is low but causes considerable morbidity due to fast progression to cirrhosis12
UEG Week 2021 Oral Presentations12
Expanding Support Beyond Clinical Care in IBD Patients12
Over‐the‐scope clip versus transcatheter arterial embolization for refractory peptic ulcer bleeding—A propensity score matched analysis12
Markers of cell death predict therapy response in patients with cirrhosis and hepatorenal syndrome12
Early diarrhoea under sorafenib as a marker to consider the early migration to second‐line drugs12
Post‐polypectomy surveillance colonoscopy: Comparison of the updated guidelines12
Best of UEG Week 202412
Updated German guideline on diagnosis and treatment of squamous cell carcinoma and adenocarcinoma of the esophagus11
Structural imaging findings are related to clinical complications in chronic pancreatitis11
Serum L‐arginine and endogenous methylarginine concentrations predict irritable bowel syndrome in adults: A nested case‐control study11
Difficult‐to‐treat inflammatory bowel disease: Effectiveness and safety of 4th and 5th lines of treatment11
German guideline diverticular disease/diverticulitis11
Implementation of endoscopic submucosal dissection in a country with a low incidence of gastric cancer: Results from a prospective national registry11
Organoid‐based precision medicine in pancreatic cancer11
How to use social media for scientific advocacy and personal branding11
UEG Week 2023 Oral Presentations11
Gastroesophageal reflux after per‐oral endoscopic myotomy is frequently asymptomatic, but leads to more severe esophagitis: A case‐control study11
Gallbladder polyps growth rate is an independent risk factor for neoplastic polyps10
European guideline on indications, performance, and clinical impact of hydrogen and methane breath tests in adult and pediatric patients: European Association for Gastroenterology, Endoscopy and Nutri10
Clinical management of patients with drug‐induced liver injury (DILI)10
The epidemiology of inflammatory bowel disease in Asia and Asian immigrants to Western countries10
Shedding a new light on gastric cancer screening10
Recurrent bleeding in a patient with hepaticojejunostomy caused by Dieulafoy's lesion10
International consensus on methodological issues in standardization of fecal calprotectin measurement in inflammatory bowel diseases10
Serum Neutrophil Biomarkers to Predict Crohn's Disease Progression and Infliximab Treatment Outcomes10
Four‐fold increased mortality rate in patients with Wilson's disease: A population‐based cohort study of 151 patients10
Budesonide orodispersible tablets for induction of remission in patients with active eosinophilic oesophagitis: A 6‐week open‐label trial of the EOS‐2 Programme10
Benign inheritable disorders of bilirubin metabolism manifested by conjugated hyperbilirubinemia–A narrative review10
Review article: Updated management of acute severe ulcerative colitis: From steroids to novel medical strategies10
Multi‐Omics Biomarkers for Predicting Efficacy of Biologic and Small‐Molecule Therapies in Adults With Inflammatory Bowel Disease: A Systematic Review10
Subclinical bowel inflammation increases healthcare resources utilization and steroid use before diagnosis of inflammatory bowel disease10
Inadequate Therapy Response on Advanced Therapy in Ulcerative Colitis Adult Patients: A Retrospective Analysis of German Health Claims Data9
Issue Information9
European guidelines for the diagnosis and treatment of pancreatic exocrine insufficiency: UEG, EPC, EDS, ESPEN, ESPGHAN, ESDO, and ESPCG evidence‐based recommendations9
Efficacy, safety and differential outcomes of immune‐chemotherapy with gemcitabine, cisplatin and durvalumab in patients with biliary tract cancers: A multicenter real world cohort9
Epithelial neutrophil localization and tight junction Claudin‐2 expression are innovative outcome predictors in inflammatory bowel disease9
A rare case of squamous cell carcinoma originating from esophageal papilloma9
Inflammatory eye disease is a risk factor for future microscopic colitis: A nationwide population‐based matched case control study9
MRI Volumetric Changes in Perianal Fistulizing Crohn's Disease: Moving Toward a Novel Outcome Measure for Therapeutic Response9
 9
Addressing the overlooked psychological and social impact of fecal incontinence in inflammatory bowel disease patients9
Overview of a national endoscopy database: The Trans.IT database and its impact on data registration quality9
Fibroblast growth factor 21 is a hepatokine involved in MASLD progression9
Update on the Pancreas: Disease Mechanisms and Therapeutic Strategies9
A milestone in screening for adherent‐invasive E. coli colonization in patients with Crohn’s disease?9
Issue Information9
Quadruple therapies show a higher eradication rate compared to standard triple therapy for Helicobacter pylori infection within the LEGACy consortium. A multicenter observational study in Europ9
Distinct trajectories of symptomatic response in ulcerative colitis during filgotinib therapy: A post hoc analysis from the SELECTION study9
Issue Information9
Translational evaluation of Gelsectan® effects on gut barrier dysfunction and visceral pain in animal models and irritable bowel syndrome with diarrhea9
8
Ustekinumab treatment in ulcerative colitis: Real‐world data from the Swedish inflammatory bowel disease quality register8
Proportion of inflammatory bowel diseases patients with suboptimal disease control in daily clinical practice—Real‐world evidence from the inflammatory bowel diseases‐podcast study8
Young GI angle: Imposter syndrome: What a young GI should know8
Letter of Thanks for UEG Week 2024 Reviewers8
Irritable bowel syndrome: Factors of importance for disease‐specific quality of life8
Raising interest for neurogastroenterology: Bottom‐up from the undergraduate medical curriculum?8
Young GI angle: How to recognize a predatory journal8
8
Prior hospital‐based infection and risk of eosinophilic esophagitis in a Swedish nationwide case‐control study8
Career beasts and how to cope with them: From toxic workplace culture to healthy competition8
Guideline for the diagnosis and treatment of Faecal Incontinence—A UEG/ESCP/ESNM/ESPCG collaboration8
Correction to “A portrait of Endoscopic retrograde cholangiopancreatography and endoscopic ultrasound training programs in Europe: Current practices and opportunities for improvement”8
How to get new guidelines in United European Gastroenterology: Follow the gold!7
Patterns of acute decompensation in hospitalized patients with cirrhosis and course of acute‐on‐chronic liver failure7
How safe are opioids in the early phase of acute pancreatitis?7
Disease clearance in ulcerative colitis: Is the ultimate therapeutic target?7
Autoimmune pancreatitis—New evidence for clinical management strategies7
UEG Journal's impact and vision for the future7
Irritable bowel syndrome and risk of glaucoma: An analysis of two independent population‐based cohort studies7
Intra‐abdominal abscesses in CD – When to treat with biologics?7
7
7
Issue Information7
Quality of clinical guidelines: It matters as it impacts patient care7
Composite outcomes in observational studies of ulcerative colitis: A systematic review and meta‐analysis7
The Workgroup Serrated Polyps and Polyposis (WASP) classification for optical diagnosis of colorectal diminutive polyps with iScan and the impact of the revised World Health Organization (WHO) criteri7
Metabolic dysfunction associated steatotic liver disease—Clinicians should not underestimate the role of steatosis7
The Pivotal ‘P’s of inflammatory bowel disease: Prediction and Prevention7
New German guidelines for the management of diverticulitis6
Comments on Post‐pancreatitis diabetes mellitus is common in chronic pancreatitis and is associated with adverse outcomes: Authors' reply6
European guidelines on functional bowel disorders with diarrhoea: United European Gastroenterology (UEG) and European Society for neurogastroenterology and motility (ESNM) statements and recommendatio6
An unusual case of multiple colonic polyps6
Dietary strategies in non‐alcoholic fatty liver disease patients: From evidence to daily clinical practice, a systematic review6
Acknowledgements6
Predictive value of Milan ultrasound criteria in ulcerative colitis: A prospective observational cohort study6
Young GI angle: Challenges in education of liver transplantation gastroenterologists6
The Japanese Esophageal Society classification for prediction of superficial esophageal squamous cell neoplasia invasion depth: Validation in a Western population6
A starch‐ and sucrose‐reduced dietary intervention in irritable bowel syndrome patients produced a shift in gut microbiota composition along with changes in phylum, genus, and amplicon sequence varian6
Guideline for the assessment and management of gastrointestinal symptoms following colorectal surgery—A UEG/ESCP/EAES/ESPCG/ESPEN/ESNM/ESSO collaboration. Part II—Good practice guidance | sequelae to 6
Association of circulating Z‐polymer with adverse clinical outcomes and liver fibrosis in adults with alpha‐1 antitrypsin deficiency6
Quality of life after endoscopic procedures for chronic pancreatitis: A multicentre study6
Prevalence of stricturing, penetrating complications and extraintestinal manifestations in inflammatory bowel disease detected on cross‐sectional imaging in a tertiary care setting6
COVID‐19 mortality in cirrhosis is determined by cirrhosis‐associated comorbidities and extrahepatic organ failure: Results from the multinational LEOSS registry6
Evolution of liver function during immune checkpoint inhibitor treatment for hepatocellular carcinoma6
How to raise the interest for neurogastroenterology among young gastroenterologists?6
miR‐10b‐5p rescues leaky gut linked with gastrointestinal dysmotility and diabetes5
The natural history of extraintestinal manifestations after surgery in inflammatory bowel disease: Never give up!5
5
Lack of evidence for the use of ustekinumab for acute severe ulcerative colitis5
Issue Information5
Young GI angle: Networking in gastroenterology—How to expand your possibilities with the UEG?5
Preclinical IBD: One more piece of the puzzle5
Issue Information5
Issue Information5
Thrombolysis for haemobilia‐induced biliary obstruction through a cholangiodrainage catheter5
Issue Information5
5
Paediatric acute liver failure: Confirm the outbreak, find the cause and explore the mechanisms5
Incidence and risk factors of oral feeding intolerance in acute pancreatitis: Results from an international, multicenter, prospective cohort study5
5
 4
Can we predict the future of patients with liver cirrhosis using volumetrics?4
Issue Information4
Interferential therapy for chronic constipation in adults: The CON‐COUR randomizedcontrolled trial4
Patient preferences for the diagnosis of coeliac disease: A discrete choice experiment4
Primary malignant melanoma of the oesophagus4
European guideline on indications, performance and clinical impact of 13C‐breath tests in adult and pediatric patients: An EAGEN, ESNM, and ESPGHAN consensus, supported by EPC4
Join the myUEG community and become an official myUEG Associate for free4
Ultrasound muscle assessment for sarcopenia detection in inflammatory bowel disease: A prospective study4
The Milan score: A novel manometric tool for a more efficient diagnosis of gastro‐esophageal reflux disease4
4
Elective percutaneous liver biopsy and use of aspirin4
4
Barrett's esophagus surveillance in a prospective Dutch multi‐center community‐based cohort of 985 patients demonstrates low risk of neoplastic progression4
Gastrointestinal Perforations Associated With JAK Inhibitors: A Disproportionality Analysis of the FDA Adverse Event Reporting System4
Drug Interaction With Advanced Therapies in Inflammatory Bowel Diseases: A Blind Spot to Tackle4
Digestive cancer screening across Europe4
Expanding ultrasound horizons in inflammatory bowel disease: Beyond the bowel4
Morbid obesity increases death and dropout from the liver transplantation waiting list: A prospective cohort study4
The guts of the matter: UEG's role in European Union health policy developments4
Increased risk of genital warts in inflammatory bowel disease: A Danish registry‐based cohort study (1996–2018)4
Standard versus Endocuff versus cap‐assisted colonoscopy for adenoma detection: A randomised controlled clinical trial4
Re: European guideline on indications, performance, and clinical impact of hydrogen and methane breath tests in adult and pediatric patients4
Corrigendum4
Issue Information4
Risk factors for the occurrence of ampullary tumors: A case‐control study4
Increased risk of second primary tumours in patients with oesophageal squamous cell carcinoma: a nationwide study in a Western population4
Cold snare polypectomy for large sessile serrated lesions is safe but follow‐up is needed: a single‐centre retrospective study4
Inflammatory bowel disease and risk of severe COVID‐19: A nationwide population‐based cohort study in Sweden4
Interactions between the metabolic syndrome and alcohol consumption increases the risk of liver disease4
Prognosis of variceal and non‐variceal upper gastrointestinal bleeding in already hospitalised patients: Results from a French prospective cohort4
Locoregional therapies for hepatocellular carcinoma: The current status and future perspectives4
CiThroModel Improves Prediction of Symptomatic Venous Thromboembolism in Hospitalized Patients With Cirrhosis Without Hepatocellular Carcinoma4
Inhibition of NAE‐dependent protein hyper‐NEDDylation in cystic cholangiocytes halts cystogenesis in experimental models of polycystic liver disease4
T1 colorectal cancer patients' perspective on information provision and therapeutic decision‐making after local resection3
Update on Autoimmune Pancreatitis and IgG4‐Related Disease3
UEG Week 2022 Oral Presentations3
Real‐time use of artificial intelligence (CADEYE) in colorectal cancer surveillance of patients with Lynch syndrome—A randomized controlled pilot trial (CADLY)3
Guideline for the assessment and management of gastrointestinal symptoms following colorectal surgery—A UEG/ESCP/EAES/ESPCG/ESPEN/ESNM/ESSO collaboration. Part I—Sequelae to oncological diseases3
Prospective Evaluation of Real‐Time Artificial Intelligence for the Hill Classification of the Gastroesophageal Junction3
Effectiveness of PPI treatment and guideline adherence in 236 patients with eosinophilic oesophagitis—Results from the population‐based DanEoE cohort shows a low complication rate3
Modifying Our Environment to Improve Outcomes in Inflammatory Bowel Diseases?3
Influence of sex in alcohol‐related liver disease: Pre‐clinical and clinical settings3
United European Gastroenterology (UEG) and European Society for Neurogastroenterology and Motility (ESNM) consensus on functional dyspepsia3
The assessment and management of cirrhotic patients with encephalopathy3
Gastric cancer detection by non‐blood‐based liquid biopsies: A systematic review looking into the last decade of research3
0.099699974060059